Stocks · Health care · Pharmaceutical Preparations

Serina Therapeutics, Inc.

SER Clue Score38
United States Fiscal year ends December CIK 0001708599 Results filed 13 Aug 2026

What the insiders did No buying or selling

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Gregory Bailey
Director
—
—
—
8,564,382
$17.39M
+13,413%
Juvenescence Ltd entity
10% owner
—
—
—
3,267,188
$6.63M
+44.1%
Jay Venkatesan
Director
—
—
—
232,294
$471.56K
—
Richard Peter Marshall
Director
—
—
—
12,183
$24.73K
—
Karen J Wilson
Director
—
—
—
10,100
$20.50K
—
Steven A Ledger
Chief Executive Officer
—
—
—
10,100
$20.50K
—
Stephen K. Brannan
Director
—
—
—
1,000
$2.03K
—
Randall Moreadith
Chief Scientific Officer
—
—
—
0
$0.00
—

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 9,932,215 to 25,400,473 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.